4.7 Article

Enhanced Cytotoxic Effect of TAT-PLGA-Embedded DOXO Carried by Biomimetic Magnetic Nanoparticles upon Combination with Magnetic Hyperthermia and Photothermia

期刊

PHARMACEUTICS
卷 13, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/pharmaceutics13081168

关键词

photothermia; hyperthermia; BMNPs; PLGA; magnetic nanoparticles; TAT peptide; doxorubicin

资金

  1. Ministerio de Economia y Competitividad [CGL2016-76723]
  2. Ministerio de Ciencia e Innovacion [PID2019-109294RB-100]
  3. Ramon y Cajal program [RYC-2014-16901]
  4. Junta de Andalucia Programa Operativo FEDER 2014-2020 [A1-FQM-341-UGR18, C-FQM-497-UGR18, A-BIO-376-UGR18]
  5. Proyectos de I + D + I, del Plan Andaluz de Investigacion, Desarrollo e Innovacion [P20_00208, P20_00346]
  6. Ministerio de Ciencia, Innovacion, y Universidades (Spain) [PRE2018-085440]
  7. Ministerio de Educacion, Ciencia, y Deporte y Competitividad (Spain) [FPU16_04580]
  8. Andalusian regional government [CTS-236]

向作者/读者索取更多资源

The synergy between directed chemotherapy and thermal therapy utilizing a nanoassembly composed of functionalized biomimetic magnetic nanoparticles (BMNPs) was explored in this study. Results demonstrated that this nanoassembly, capable of mediating drug transport and hyperthermic effects, showed a stronger cytotoxic effect against tumor cells both in vitro and in vivo compared to traditional therapies.
The synergy between directed chemotherapy and thermal therapy (both magnetic hyperthermia and photothermia) mediated by a nanoassembly composed of functionalized biomimetic magnetic nanoparticles (BMNPs) with the chemotherapeutic drug doxorubicin (DOXO) covered by the polymer poly(lactic-co-glycolic acid) (PLGA), decorated with TAT peptide (here referred to as TAT-PLGA(DOXO-BMNPs)) is explored in the present study. The rationale behind this nanoassembly lies in an optimization of the nanoformulation DOXO-BMNPs, already demonstrated to be more efficient against tumor cells, both in vitro and in vivo, than systemic traditional therapies. By embedding DOXO-BMNPs into PLGA, which is further functionalized with the cell-penetrating TAT peptide, the resulting nanoassembly is able to mediate drug transport (using DOXO as a drug model) and behaves as a hyperthermic agent (induced by an alternating magnetic field (AMF) or by laser irradiation with a laser power density of 2 W/cm(2)). Our results obtained using the HepG2 cell line show that there is a synergy between chemotherapy and thermal therapy that results in a stronger cytotoxic effect when compared to that caused by the soluble DOXO. This is probably due to the enhanced DOXO release occurring upon the application of the thermal therapy, as well as the induced local temperature rise mediated by BMNPs in the nanoassembly following exposition to AMF or to near-infrared (NIR) laser irradiation. These results represent a proof of concept demonstrating that TAT-PLGA(DOXO-BMNPs) can be used to efficiently combine therapies against tumor cells, which is a step forward in the transition from systemic to local treatments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据